Drug manufacturer Dr Reddy's Laboratories today said it has received US regulatory approval for anti-heartburn capsules.
The company has received US Food and Drug Administration approval for its Abbreviated New Drug Application for Omeprazole Mg OTC, Dr Reddy's Laboratories said in a filing to the Bombay Stock Exchange.
Omeprazole Mg OTC is indicated for the treatment of heartburn.
Dr Reddy's formulation contains 20.6 mg Omeprazole Mg and the dosage form is a capsule, the filing added.
